0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tissue Engineered Heart Valve Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-3W8760
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Tissue Engineered Heart Valve Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tissue Engineered Heart Valve Market Research Report 2023

Code: QYRE-Auto-3W8760
Report
March 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Tissue Engineered Heart Valve Market

The global Tissue Engineered Heart Valve market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Tissue Engineered Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tissue Engineered Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Tissue Engineered Heart Valve include Medtronic, Edwards Lifesciences Corporation, Boston Scientific, Abbott, LivaNova PLC, Symetis SA, CryoLife, TTK Healthcare Limited and Colibri Heart Valve, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tissue Engineered Heart Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Engineered Heart Valve.
The Tissue Engineered Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tissue Engineered Heart Valve market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Engineered Heart Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific
  • Abbott
  • LivaNova PLC
  • Symetis SA
  • CryoLife
  • TTK Healthcare Limited
  • Colibri Heart Valve
  • Lepu Medical Technology

Segment by Type

  • Transcatheter Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves

Segment by Application

  • Heart Surgery
  • Cardiovascular Disease
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tissue Engineered Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tissue Engineered Heart Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Tissue Engineered Heart Valve Market Report

Report MetricDetails
Report NameGlobal Tissue Engineered Heart Valve Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Tissue Engineered Heart Valve Market Overview
1.1 Product Overview and Scope of Tissue Engineered Heart Valve
1.2 Tissue Engineered Heart Valve Segment by Type
1.2.1 Global Tissue Engineered Heart Valve Market Value Comparison by Type (2023-2029)
1.2.2 Transcatheter Heart Valves
1.2.3 Tissue Heart Valves
1.2.4 Mechanical Heart Valves
1.3 Tissue Engineered Heart Valve Segment by Application
1.3.1 Global Tissue Engineered Heart Valve Market Value by Application: (2023-2029)
1.3.2 Heart Surgery
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Global Tissue Engineered Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Tissue Engineered Heart Valve Revenue 2018-2029
1.4.2 Global Tissue Engineered Heart Valve Sales 2018-2029
1.4.3 Global Tissue Engineered Heart Valve Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tissue Engineered Heart Valve Market Competition by Manufacturers
2.1 Global Tissue Engineered Heart Valve Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tissue Engineered Heart Valve Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tissue Engineered Heart Valve Average Price by Manufacturers (2018-2023)
2.4 Global Tissue Engineered Heart Valve Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tissue Engineered Heart Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tissue Engineered Heart Valve, Product Type & Application
2.7 Tissue Engineered Heart Valve Market Competitive Situation and Trends
2.7.1 Tissue Engineered Heart Valve Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tissue Engineered Heart Valve Players Market Share by Revenue
2.7.3 Global Tissue Engineered Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tissue Engineered Heart Valve Retrospective Market Scenario by Region
3.1 Global Tissue Engineered Heart Valve Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tissue Engineered Heart Valve Global Tissue Engineered Heart Valve Sales by Region: 2018-2029
3.2.1 Global Tissue Engineered Heart Valve Sales by Region: 2018-2023
3.2.2 Global Tissue Engineered Heart Valve Sales by Region: 2024-2029
3.3 Global Tissue Engineered Heart Valve Global Tissue Engineered Heart Valve Revenue by Region: 2018-2029
3.3.1 Global Tissue Engineered Heart Valve Revenue by Region: 2018-2023
3.3.2 Global Tissue Engineered Heart Valve Revenue by Region: 2024-2029
3.4 North America Tissue Engineered Heart Valve Market Facts & Figures by Country
3.4.1 North America Tissue Engineered Heart Valve Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tissue Engineered Heart Valve Sales by Country (2018-2029)
3.4.3 North America Tissue Engineered Heart Valve Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tissue Engineered Heart Valve Market Facts & Figures by Country
3.5.1 Europe Tissue Engineered Heart Valve Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tissue Engineered Heart Valve Sales by Country (2018-2029)
3.5.3 Europe Tissue Engineered Heart Valve Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Engineered Heart Valve Market Facts & Figures by Country
3.6.1 Asia Pacific Tissue Engineered Heart Valve Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tissue Engineered Heart Valve Sales by Country (2018-2029)
3.6.3 Asia Pacific Tissue Engineered Heart Valve Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tissue Engineered Heart Valve Market Facts & Figures by Country
3.7.1 Latin America Tissue Engineered Heart Valve Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tissue Engineered Heart Valve Sales by Country (2018-2029)
3.7.3 Latin America Tissue Engineered Heart Valve Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tissue Engineered Heart Valve Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Engineered Heart Valve Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tissue Engineered Heart Valve Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tissue Engineered Heart Valve Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tissue Engineered Heart Valve Sales by Type (2018-2029)
4.1.1 Global Tissue Engineered Heart Valve Sales by Type (2018-2023)
4.1.2 Global Tissue Engineered Heart Valve Sales by Type (2024-2029)
4.1.3 Global Tissue Engineered Heart Valve Sales Market Share by Type (2018-2029)
4.2 Global Tissue Engineered Heart Valve Revenue by Type (2018-2029)
4.2.1 Global Tissue Engineered Heart Valve Revenue by Type (2018-2023)
4.2.2 Global Tissue Engineered Heart Valve Revenue by Type (2024-2029)
4.2.3 Global Tissue Engineered Heart Valve Revenue Market Share by Type (2018-2029)
4.3 Global Tissue Engineered Heart Valve Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tissue Engineered Heart Valve Sales by Application (2018-2029)
5.1.1 Global Tissue Engineered Heart Valve Sales by Application (2018-2023)
5.1.2 Global Tissue Engineered Heart Valve Sales by Application (2024-2029)
5.1.3 Global Tissue Engineered Heart Valve Sales Market Share by Application (2018-2029)
5.2 Global Tissue Engineered Heart Valve Revenue by Application (2018-2029)
5.2.1 Global Tissue Engineered Heart Valve Revenue by Application (2018-2023)
5.2.2 Global Tissue Engineered Heart Valve Revenue by Application (2024-2029)
5.2.3 Global Tissue Engineered Heart Valve Revenue Market Share by Application (2018-2029)
5.3 Global Tissue Engineered Heart Valve Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Tissue Engineered Heart Valve Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Edwards Lifesciences Corporation
6.2.1 Edwards Lifesciences Corporation Corporation Information
6.2.2 Edwards Lifesciences Corporation Description and Business Overview
6.2.3 Edwards Lifesciences Corporation Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Edwards Lifesciences Corporation Tissue Engineered Heart Valve Product Portfolio
6.2.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Tissue Engineered Heart Valve Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Tissue Engineered Heart Valve Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 LivaNova PLC
6.5.1 LivaNova PLC Corporation Information
6.5.2 LivaNova PLC Description and Business Overview
6.5.3 LivaNova PLC Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LivaNova PLC Tissue Engineered Heart Valve Product Portfolio
6.5.5 LivaNova PLC Recent Developments/Updates
6.6 Symetis SA
6.6.1 Symetis SA Corporation Information
6.6.2 Symetis SA Description and Business Overview
6.6.3 Symetis SA Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Symetis SA Tissue Engineered Heart Valve Product Portfolio
6.6.5 Symetis SA Recent Developments/Updates
6.7 CryoLife
6.6.1 CryoLife Corporation Information
6.6.2 CryoLife Description and Business Overview
6.6.3 CryoLife Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CryoLife Tissue Engineered Heart Valve Product Portfolio
6.7.5 CryoLife Recent Developments/Updates
6.8 TTK Healthcare Limited
6.8.1 TTK Healthcare Limited Corporation Information
6.8.2 TTK Healthcare Limited Description and Business Overview
6.8.3 TTK Healthcare Limited Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.8.4 TTK Healthcare Limited Tissue Engineered Heart Valve Product Portfolio
6.8.5 TTK Healthcare Limited Recent Developments/Updates
6.9 Colibri Heart Valve
6.9.1 Colibri Heart Valve Corporation Information
6.9.2 Colibri Heart Valve Description and Business Overview
6.9.3 Colibri Heart Valve Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Colibri Heart Valve Tissue Engineered Heart Valve Product Portfolio
6.9.5 Colibri Heart Valve Recent Developments/Updates
6.10 Lepu Medical Technology
6.10.1 Lepu Medical Technology Corporation Information
6.10.2 Lepu Medical Technology Description and Business Overview
6.10.3 Lepu Medical Technology Tissue Engineered Heart Valve Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lepu Medical Technology Tissue Engineered Heart Valve Product Portfolio
6.10.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Engineered Heart Valve Industry Chain Analysis
7.2 Tissue Engineered Heart Valve Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Engineered Heart Valve Production Mode & Process
7.4 Tissue Engineered Heart Valve Sales and Marketing
7.4.1 Tissue Engineered Heart Valve Sales Channels
7.4.2 Tissue Engineered Heart Valve Distributors
7.5 Tissue Engineered Heart Valve Customers
8 Tissue Engineered Heart Valve Market Dynamics
8.1 Tissue Engineered Heart Valve Industry Trends
8.2 Tissue Engineered Heart Valve Market Drivers
8.3 Tissue Engineered Heart Valve Market Challenges
8.4 Tissue Engineered Heart Valve Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Tissue Engineered Heart Valve Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Tissue Engineered Heart Valve Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Tissue Engineered Heart Valve Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Tissue Engineered Heart Valve Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Tissue Engineered Heart Valve Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Tissue Engineered Heart Valve Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Tissue Engineered Heart Valve Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Tissue Engineered Heart Valve Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Tissue Engineered Heart Valve, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Tissue Engineered Heart Valve, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Tissue Engineered Heart Valve, Product Type & Application
    Table 12. Global Key Manufacturers of Tissue Engineered Heart Valve, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tissue Engineered Heart Valve by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue Engineered Heart Valve as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tissue Engineered Heart Valve Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Tissue Engineered Heart Valve Sales by Region (2018-2023) & (K Units)
    Table 18. Global Tissue Engineered Heart Valve Sales Market Share by Region (2018-2023)
    Table 19. Global Tissue Engineered Heart Valve Sales by Region (2024-2029) & (K Units)
    Table 20. Global Tissue Engineered Heart Valve Sales Market Share by Region (2024-2029)
    Table 21. Global Tissue Engineered Heart Valve Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Tissue Engineered Heart Valve Revenue Market Share by Region (2018-2023)
    Table 23. Global Tissue Engineered Heart Valve Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Tissue Engineered Heart Valve Revenue Market Share by Region (2024-2029)
    Table 25. North America Tissue Engineered Heart Valve Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Tissue Engineered Heart Valve Sales by Country (2018-2023) & (K Units)
    Table 27. North America Tissue Engineered Heart Valve Sales by Country (2024-2029) & (K Units)
    Table 28. North America Tissue Engineered Heart Valve Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Tissue Engineered Heart Valve Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Tissue Engineered Heart Valve Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Tissue Engineered Heart Valve Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Tissue Engineered Heart Valve Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Tissue Engineered Heart Valve Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Tissue Engineered Heart Valve Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Tissue Engineered Heart Valve Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Tissue Engineered Heart Valve Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Tissue Engineered Heart Valve Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Tissue Engineered Heart Valve Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Tissue Engineered Heart Valve Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Tissue Engineered Heart Valve Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Tissue Engineered Heart Valve Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Tissue Engineered Heart Valve Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Tissue Engineered Heart Valve Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Tissue Engineered Heart Valve Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Tissue Engineered Heart Valve Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Tissue Engineered Heart Valve Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Tissue Engineered Heart Valve Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Tissue Engineered Heart Valve Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Tissue Engineered Heart Valve Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Tissue Engineered Heart Valve Sales (K Units) by Type (2018-2023)
    Table 51. Global Tissue Engineered Heart Valve Sales (K Units) by Type (2024-2029)
    Table 52. Global Tissue Engineered Heart Valve Sales Market Share by Type (2018-2023)
    Table 53. Global Tissue Engineered Heart Valve Sales Market Share by Type (2024-2029)
    Table 54. Global Tissue Engineered Heart Valve Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Tissue Engineered Heart Valve Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Tissue Engineered Heart Valve Revenue Market Share by Type (2018-2023)
    Table 57. Global Tissue Engineered Heart Valve Revenue Market Share by Type (2024-2029)
    Table 58. Global Tissue Engineered Heart Valve Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Tissue Engineered Heart Valve Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Tissue Engineered Heart Valve Sales (K Units) by Application (2018-2023)
    Table 61. Global Tissue Engineered Heart Valve Sales (K Units) by Application (2024-2029)
    Table 62. Global Tissue Engineered Heart Valve Sales Market Share by Application (2018-2023)
    Table 63. Global Tissue Engineered Heart Valve Sales Market Share by Application (2024-2029)
    Table 64. Global Tissue Engineered Heart Valve Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Tissue Engineered Heart Valve Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Tissue Engineered Heart Valve Revenue Market Share by Application (2018-2023)
    Table 67. Global Tissue Engineered Heart Valve Revenue Market Share by Application (2024-2029)
    Table 68. Global Tissue Engineered Heart Valve Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Tissue Engineered Heart Valve Price (USD/Unit) by Application (2024-2029)
    Table 70. Medtronic Corporation Information
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Medtronic Tissue Engineered Heart Valve Product
    Table 74. Medtronic Recent Developments/Updates
    Table 75. Edwards Lifesciences Corporation Corporation Information
    Table 76. Edwards Lifesciences Corporation Description and Business Overview
    Table 77. Edwards Lifesciences Corporation Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Edwards Lifesciences Corporation Tissue Engineered Heart Valve Product
    Table 79. Edwards Lifesciences Corporation Recent Developments/Updates
    Table 80. Boston Scientific Corporation Information
    Table 81. Boston Scientific Description and Business Overview
    Table 82. Boston Scientific Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Boston Scientific Tissue Engineered Heart Valve Product
    Table 84. Boston Scientific Recent Developments/Updates
    Table 85. Abbott Corporation Information
    Table 86. Abbott Description and Business Overview
    Table 87. Abbott Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Abbott Tissue Engineered Heart Valve Product
    Table 89. Abbott Recent Developments/Updates
    Table 90. LivaNova PLC Corporation Information
    Table 91. LivaNova PLC Description and Business Overview
    Table 92. LivaNova PLC Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. LivaNova PLC Tissue Engineered Heart Valve Product
    Table 94. LivaNova PLC Recent Developments/Updates
    Table 95. Symetis SA Corporation Information
    Table 96. Symetis SA Description and Business Overview
    Table 97. Symetis SA Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Symetis SA Tissue Engineered Heart Valve Product
    Table 99. Symetis SA Recent Developments/Updates
    Table 100. CryoLife Corporation Information
    Table 101. CryoLife Description and Business Overview
    Table 102. CryoLife Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. CryoLife Tissue Engineered Heart Valve Product
    Table 104. CryoLife Recent Developments/Updates
    Table 105. TTK Healthcare Limited Corporation Information
    Table 106. TTK Healthcare Limited Description and Business Overview
    Table 107. TTK Healthcare Limited Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. TTK Healthcare Limited Tissue Engineered Heart Valve Product
    Table 109. TTK Healthcare Limited Recent Developments/Updates
    Table 110. Colibri Heart Valve Corporation Information
    Table 111. Colibri Heart Valve Description and Business Overview
    Table 112. Colibri Heart Valve Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Colibri Heart Valve Tissue Engineered Heart Valve Product
    Table 114. Colibri Heart Valve Recent Developments/Updates
    Table 115. Lepu Medical Technology Corporation Information
    Table 116. Lepu Medical Technology Description and Business Overview
    Table 117. Lepu Medical Technology Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Lepu Medical Technology Tissue Engineered Heart Valve Product
    Table 119. Lepu Medical Technology Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Tissue Engineered Heart Valve Distributors List
    Table 123. Tissue Engineered Heart Valve Customers List
    Table 124. Tissue Engineered Heart Valve Market Trends
    Table 125. Tissue Engineered Heart Valve Market Drivers
    Table 126. Tissue Engineered Heart Valve Market Challenges
    Table 127. Tissue Engineered Heart Valve Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tissue Engineered Heart Valve
    Figure 2. Global Tissue Engineered Heart Valve Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Tissue Engineered Heart Valve Market Share by Type in 2022 & 2029
    Figure 4. Transcatheter Heart Valves Product Picture
    Figure 5. Tissue Heart Valves Product Picture
    Figure 6. Mechanical Heart Valves Product Picture
    Figure 7. Global Tissue Engineered Heart Valve Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Tissue Engineered Heart Valve Market Share by Application in 2022 & 2029
    Figure 9. Heart Surgery
    Figure 10. Cardiovascular Disease
    Figure 11. Others
    Figure 12. Global Tissue Engineered Heart Valve Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Tissue Engineered Heart Valve Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Tissue Engineered Heart Valve Sales (2018-2029) & (K Units)
    Figure 15. Global Tissue Engineered Heart Valve Average Price (USD/Unit) & (2018-2029)
    Figure 16. Tissue Engineered Heart Valve Report Years Considered
    Figure 17. Tissue Engineered Heart Valve Sales Share by Manufacturers in 2022
    Figure 18. Global Tissue Engineered Heart Valve Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Tissue Engineered Heart Valve Players: Market Share by Revenue in 2022
    Figure 20. Tissue Engineered Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Tissue Engineered Heart Valve Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Tissue Engineered Heart Valve Sales Market Share by Country (2018-2029)
    Figure 23. North America Tissue Engineered Heart Valve Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Tissue Engineered Heart Valve Sales Market Share by Country (2018-2029)
    Figure 27. Europe Tissue Engineered Heart Valve Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Tissue Engineered Heart Valve Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Tissue Engineered Heart Valve Revenue Market Share by Region (2018-2029)
    Figure 35. China Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Tissue Engineered Heart Valve Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Tissue Engineered Heart Valve Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Tissue Engineered Heart Valve Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Tissue Engineered Heart Valve Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. U.A.E Tissue Engineered Heart Valve Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Tissue Engineered Heart Valve by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Tissue Engineered Heart Valve by Type (2018-2029)
    Figure 57. Global Tissue Engineered Heart Valve Price (USD/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Tissue Engineered Heart Valve by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Tissue Engineered Heart Valve by Application (2018-2029)
    Figure 60. Global Tissue Engineered Heart Valve Price (USD/Unit) by Application (2018-2029)
    Figure 61. Tissue Engineered Heart Valve Value Chain
    Figure 62. Tissue Engineered Heart Valve Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS